GSK Description — GSK plc

GSK is a biopharma company. Co. is engaged in making vaccines and specialty medicines to prevent and treat disease. Co.'s research and development focuses on the science of the immune system, human genetics and advanced technologies primarily in the following four therapeutic areas: infectious diseases, HIV, oncology and immunology/respiratory. Co.'s two reportable segments include: Commercial Operations and Total research and development.

Company Name: 
GSK plc
Drugs & Pharmaceuticals
Number of ETFs Holding GSK: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 
 ETF   GSK Weight   GSK Amount 
 PPH   4.32%   $16,422,137         
Quotes delayed 20 minutes

Email EnvelopeFree GSK Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Sell (1.29 out of 4)
0th percentile
(ranked lower than approx. 100% of all stocks covered)

Analysts Forecast:
GSK Price Target

Based on data provided by Zacks Investment Research via

ETFs Holding GSK | GSK plc | ETF Channel |

Copyright © 2010 - 2023, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.